ALICIA ANDERSON: Open Payments
NPI 1093075269 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 23 payments from 12 companies in 2025. Trend: 2023 $568 · 2024 $774 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $84 |
| ABBVIE INC. | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 1 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| PFIZER INC. | 2 | $36 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Recor Medical Inc | 1 | $26 |
| Exact Sciences Corporation | 1 | $21 |
Products named: Qelbree, CAPLYTA, NURTEC ODT, QULIPTA, NEFFY, MOUNJARO, Paradise Ultrasound Renal Denervation System, Rybelsus.
Industry payments across SC — which companies pay providers there.
